Mai H. Le

2.4k citations
26 papers · 589 indexed · h-index 12
Topics
Multiple Myeloma Research and Treatments (6 papers)Protein Degradation and Inhibitors (6 papers)Ubiquitin and proteasome pathways (6 papers)

In The Last Decade

Mai H. Le

26 papers receiving 571 citations

Peers

Mai H. Le
Comparison fields: 5 of 81
  • Immunology 236
  • Oncology 219
  • Molecular Biology 200
  • Hematology 93
  • Biotechnology 74
Replace Mirjana Urosevic‐Maiwald with:
Mirjana Urosevic‐Maiwald Switzerland
Rossella Fasano Italy
Oppenheim Jj United States
Geertje J. D. van Mierlo Netherlands
Ruodan Nan United Kingdom
Lori Clarke United States
Virginia Andreani Germany
Angela Barone Sweden
Nigel Francis United Kingdom
N Duinkerken Netherlands
Mai H. Le relative to Mirjana Urosevic‐Maiwald Switzerland Mirjana Urosevic‐Maiwald's profile →
Citations per field
00.5×10.3×
Mirjana Urosevic‐Maiwald · 1×
Citations per year

Countries citing papers authored by Mai H. Le

Since Specialization
Citations

This map shows the geographic impact of Mai H. Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai H. Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai H. Le more than expected).

Fields of papers citing papers by Mai H. Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai H. Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai H. Le. The network helps show where Mai H. Le may publish in the future.

Co-authorship network of co-authors of Mai H. Le

This figure shows the co-authorship network connecting the top 25 collaborators of Mai H. Le. A scholar is included among the top collaborators of Mai H. Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai H. Le. Mai H. Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 34
3 11
4 70
5 68
6 41
7 4
8 6
9 4
10 10
11 4
12 11
13 5
14 8
15
Barriers to utilization of dental services during pregnancy: a qualitative analysis.
47
16 13
17 19
18 13
19 6
20 4

About Mai H. Le

Mai H. Le is a scholar working on Hematology, Biotechnology and Oncology, having authored 26 papers that have together received 589 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Immunology (236 citations), Periodontics (42 citations) and Biotechnology (74 citations). Mai H. Le has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert H. Pierce, Adil Daud, Brian L. West, Chris Twitty, Peter Milgrom, Philip Weinstein, Christine A. Riedy, Paul Severson, Lisa M. Coussens and David A. Karlin. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026